Friedreich's Ataxia: a review from a cardiology perspective
1Cardiac Arrhythmia Service, St Vincent's University Hospital, Elm Park, Dublin, Ireland. tarabourke@hotmail.com
Insights
Friedreich's Ataxia (FA) frequently causes hypertrophic cardiomyopathy. Early screening and aggressive treatment for cardiac issues in FA patients can improve quality of life and survival.
Area of Science:
- Cardiology
- Neurology
- Genetics
Background:
- Cardiomyopathy is not common in the general population but is a known complication in certain neuromuscular disorders.
- Friedreich's Ataxia (FA) is a neuromuscular disorder associated with cardiomyopathy.
- Cardiac involvement in neuromuscular disorders significantly increases morbidity and mortality.
Purpose of the Study:
- To review the literature on cardiac involvement in Friedreich's Ataxia.
- To highlight the importance of cardiac screening in FA patients.
Main Methods:
- Extensive literature search of Medline and Pubmed.
- Inclusion of all published reports on cardiac involvement in FA.
- Identification of secondary articles from reference listings.
Main Results:
- Hypertrophic cardiomyopathy is a key feature of FA.
- Cardiac involvement in FA requires careful monitoring and management.
Conclusions:
- All patients with Friedreich's Ataxia should be screened for cardiomyopathy.
- Cardiac examination, ECG, and ECHO are recommended at diagnosis and upon symptom development.
- Treatment strategies depend on symptoms, left ventricular outflow gradient, and sudden death risk.
- Early, aggressive medical therapy may enhance quality of life and survival in FA patients.
Background:
Neuromuscular disorders are not among the common causes of cardiomyopathy in the general population; however, cardiomyopathy is known to occur in several neuromuscular disorders including Friedreich's Ataxia (FA). In patients with neuromuscular disorders, concomitant cardiac involvement contributes significantly to morbidity and mortality and often leads to premature death.
Methods:
An extensive literature search of Medline and Pubmed was conducted to include all published reports on cardiac involvement in FA. Secondary articles were identified from key paper reference listings.
Conclusion:
Hypertrophic cardiomyopathy is a cardinal feature of FA; therefore all FA patients should be screened for cardiomyopathy. A cardiac examination, ECG and ECHO are advised at diagnosis, and also on the development of any cardiac symptoms. Treatment is determined by the presence of symptoms, the presence of left ventricular outflow gradient and the sudden death risk. Institution of aggressive medical therapy early in the course of the disease may help improve quality of life and provide survival benefit.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy VI: Nursing Management


